SANDU PHARMACEUTICALS LTD.

Sandu Pharmaceuticals is a small pharmaceutical company that manufactures and sells pharmaceutical products, with operations in Goa and Mumbai. The company has been investing in plant modernization, civil works, machinery, and marketing infrastructure, indicating ongoing upgrades to its manufacturing base and distribution set-up. It reported revenue of Rs 69.93 crore in FY26 with an EBITDA margin of 4.9% and a net profit of Rs 1.77 crore. The cost shape shows raw materials at 15.7% of revenue, employees at 15.3%, and other operating expenses at 35.3%, pointing to a branded-formulation style model where marketing, distribution, and other operating costs dominate over input costs. The company carries no outstanding borrowings, and cash and cash equivalents stood at Rs 590.7 lakhs at end-FY26 versus Rs 130.39 lakhs in the prior year. It is promoter-driven and the board has recommended a final dividend of Rs 1 per equity share (10% on face value of Rs 10) for FY26.